The Effects of Preoperative Inflammation on the Analgesic
Efficacy of Intraarticular Piroxicam for Outpatient
Knee Arthroscopy
Seval Izdes, MD*, Sibel Orhun, MD†, Sacit Turanli, MD‡ Ezgi Erkilic, MD*, and Orhan Kanbak, MD*
From the Departments of *Anesthesia, †Pathology, and ‡Orthopaedic Surgery, Emergency And Traumatology Hospital,
Ankara, Turkey
We conducted a double-blinded study in 90 patients
undergoing elective arthroscopic knee surgery to deter-
mine whether there is a role of inflammation in the an-
algesic efficacy of intraarticular piroxicam. Standard-
ized general anesthetic techniques were used for all
patients. At the end of the operation, after harvesting
synovial biopsies, patients were randomized into three
intraarticular groups equally. Group 1 received 25 mL
saline, Group 2 received 25 mL 0.25% bupivacaine, and
Group 3 received 25 mL 0.25% bupivacaine and piroxi-
cam 20 mg. After microscopic examination of the syno-
vial materials, the patients were divided into two sub-
groups, inflammation positive (I+) and inflammation
negative (I-). Preoperatively and postoperatively at 1,
2, 4, and 6 h, pain levels, analgesic duration, and post-
operative analgesic consumption were recorded. Anal-
gesic duration was significantly longer in the I+ sub-
group than the I- subgroup of Group 3 (P 0.05). Pain
scores at 1, 2, and 4 h postoperatively were significantly
lower in the I+ subgroup than the I- subgroup of
Group 3 (P 0.05), whereas there were no significant
differences among the subgroups of Group 1 and 2. We
concluded that preoperative inflammation is one of the
most important determinants of analgesic efficacy of in-
traarticular piroxicam.
(Anesth Analg 2003;97:1016 –9)
A
rthroscopy of the knee joint is one of the most
common operations performed on an ambula-
tory basis. The success of ambulatory surgery
depends to some extent on effective control of post-
operative pain. A variety of analgesic techniques have
been used to manage postoperative pain after arthro-
scopic knee surgery. The ideal would be to provide
adequate local analgesia of long duration without any
side effects (1,2). Intraarticular drug use has become
widespread, and thus local anesthetics, opioids, and
nonsteroidal antiinflammatory drugs (NSAIDs) alone
or in combined forms are used to enhance their effec-
tiveness (2– 4) in providing satisfactory analgesia after
day-case knee arthroscopies. However, NSAIDs ad-
ministered intraarticularly produce conflicting data
with respect to their analgesic efficacy (3,5). These
controversial results may be related to the presence of
inflammation in the joint space structures before the
operation. This clinical trial was therefore designed to
determine whether preoperative inflammation has a
role in analgesic efficacy of intraarticular piroxicam
after arthroscopic knee surgery.
Methods
After obtaining local ethics committee approval and
written informed consent, 90 unpremedicated ASA
physical status I and II patients scheduled for outpa-
tient arthroscopic knee surgery were enrolled in the
study. Patients receiving analgesics preoperatively,
having a contraindication to receive NSAIDs, or re-
quiring knee drainage were excluded from the study.
Before the operation all patients received instructions
for using a 10-cm visual analog scale (VAS), with 0 =
no pain to 10 = the worst imaginable pain, and base-
line pain scores at rest were recorded. In all patients,
anesthesia was induced with propofol 2.5 mg/kg IV
and alfentanil 10 g/kg IV and laryngeal masks (no:
3/4) were placed. Anesthesia was maintained with
1.5%–2% sevoflurane and 65% nitrous oxide in oxy-
gen. No other supplementary analgesic medication
was given during the operation after the first dose of
Accepted for publication May 23, 2003. Presented in part at the
10th ESA Anniversary Meeting and 24th EAA Annual Meeting
Euroanaesthesia 2002, Nice, France, 6 –9 April 2002.
Address correspondence and reprint requests to Seval Izdes, MD,
39 Sokak No:11/3 06500, Bahcelievler Ankara, Turkey. Address
email to sevalizdes@yahoo.com.
DOI: 10.1213/01.ANE.0000081725.81280.17
©2003 by the International Anesthesia Research Society
1016 Anesth Analg 2003;97:1016–9 0003-2999/03